Chinese Expert Consensus on management of intrahepatic cholangiocarcinoma

Title: Chinese Expert Consensus on management of intrahepatic cholangiocarcinoma
Edition: Original
Classification: Experts consensus
Field: Diagnosis and Treatment
Countries and regions: China
Guidelines users: This guideline is aimed for whom engaged in the diagnosis, treatment and healthcare management of intrahepatic cholangiocarcinoma.
Evidence classification method: The level of evidence was graded according to the Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence.
Development unit: 中国抗癌协会肝癌专业委员会胆管癌协作组
Registration time: 2022-04-27
Registration number: IPGRP-2022CN249
Purpose of the guideline: In order to guide the clinical practice of intrahepatic cholangiocarcinoma diagnosis and treatment in a more detailed manner and improve the prognosis of patients with intrahepatic cholangiocarcinoma. The Chinese Society of Liver Cancer (CSLC) Cholangiocarcinoma Cooperative Group reviewed all the evidence related to the treatment of intrahepatic cholangiocarcinoma, and came into consensus to standardize the diagnosis and treatment of intrahepatic cholangiocarcinoma.